SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003153
Filing Date
2022-11-10
Accepted
2022-11-10 16:37:37
Documents
48
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20220930x10q.htm   iXBRL 10-Q 1336041
2 EXHIBIT 31.1 ckpt-20220930xex31d1.htm EX-31._1 10728
3 EXHIBIT 31.2 ckpt-20220930xex31d2.htm EX-31._2 10502
4 EXHIBIT 32.1 ckpt-20220930xex32d1.htm EX-32._1 6038
5 EXHIBIT 32.2 ckpt-20220930xex32d2.htm EX-32._2 5911
  Complete submission text file 0001410578-22-003153.txt   4803449

Data Files

Seq Description Document Type Size
6 EX-101.SCH ckpt-20220930.xsd EX-101.SCH 37739
7 EX-101.CAL ckpt-20220930_cal.xml EX-101.CAL 21602
8 EX-101.DEF ckpt-20220930_def.xml EX-101.DEF 168375
9 EX-101.LAB ckpt-20220930_lab.xml EX-101.LAB 333761
10 EX-101.PRE ckpt-20220930_pre.xml EX-101.PRE 249781
42 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20220930x10q_htm.xml XML 656731
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 221377932
SIC: 2834 Pharmaceutical Preparations